Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
Clinical trial NCT04531631 · COMPLETED
Trial details
- NCT number
- NCT04531631
- Sponsor
- Chinese University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2022-02-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.